Friday, 15 November 2024
  
Login

Australia's most trusted
source of pharma news

Friday, 15 November 2024
News

Top-selling PBS drug takes off

Posted 13 November 2024 AM

MSD's Keytruda well and truly maintained its top ranking as the most reimbursed drug on the PBS over the third financial quarter with sales soaring by 43.5 per cent year-on-year.

The cancer blockbuster earned $50.7 million more than it did a year earlier. It also pulled in $10.7 million more than it did in the second quarter, for a 6.8 per cent quarter-on-quarter growth rate.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (15)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (1)

Other (11)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.